BIO-TECHNE Corp Stock-Based Compensation
BIO-TECHNE Corp (TECH) reported Stock-Based Compensation of $41.37 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-24
- BIO-TECHNE Corp share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $5.23M, a 14.95% increase year-over-year.
- BIO-TECHNE Corp share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $10.49M, a 7.87% decline year-over-year.
- BIO-TECHNE Corp share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $13.96M, a 5.10% decline year-over-year.
- BIO-TECHNE Corp share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $11.68M, a 14.71% increase year-over-year.
- BIO-TECHNE Corp share-based payment arrangement, noncash expense for fiscal 2026 was $41.37M, a 1.30% increase from fiscal 2025.
- BIO-TECHNE Corp share-based payment arrangement, noncash expense for fiscal 2025 was $40.83M, a 7.34% increase from fiscal 2024.
- BIO-TECHNE Corp share-based payment arrangement, noncash expense for fiscal 2024 was $38.04M, a 3.03% decline from fiscal 2023.
- BIO-TECHNE Corp share-based payment arrangement, noncash expense for fiscal 2023 was $39.23M, a 7.00% decline from fiscal 2022.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $15.72M derived: sum of 2 quarters · filed 2026-08-24 | $29.68M derived: sum of 3 quarters · filed 2026-08-24 | $41.37M 10-K · filed 2026-08-24 |
| 2026-03-31 | $10.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | $24.45M derived: sum of 2 quarters · filed 2026-05-06 | $36.13M 10-Q · filed 2026-05-06 | $40.69M derived: sum of 4 quarters · filed 2026-08-24 |
| 2025-12-31 | $13.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | $25.64M 10-Q · filed 2026-02-04 | $30.19M derived: sum of 3 quarters · filed 2026-08-24 | $41.58M derived: sum of 4 quarters · filed 2026-08-24 |
| 2025-09-30 | $11.68M 10-Q · filed 2025-11-05 | $16.23M derived: sum of 2 quarters · filed 2026-08-24 | $27.62M derived: sum of 3 quarters · filed 2026-08-24 | $42.33M derived: sum of 4 quarters · filed 2026-08-24 |
| 2025-06-30 | $4.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $15.94M derived: sum of 2 quarters · filed 2026-08-24 | $30.65M derived: sum of 3 quarters · filed 2026-08-24 | $40.83M 10-K · filed 2026-08-24 |
| 2025-03-31 | $11.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | $26.10M derived: sum of 2 quarters · filed 2026-05-06 | $36.28M 10-Q · filed 2026-05-06 | $43.35M derived: sum of 4 quarters · filed 2026-08-24 |
| 2024-12-31 | $14.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | $24.89M 10-Q · filed 2026-02-04 | $31.95M derived: sum of 3 quarters · filed 2026-08-24 | $40.09M derived: sum of 4 quarters · filed 2026-08-24 |
| 2024-09-30 | $10.18M 10-Q · filed 2025-11-05 | $17.25M derived: sum of 2 quarters · filed 2026-08-24 | $25.38M derived: sum of 3 quarters · filed 2026-08-24 | $38.13M derived: sum of 4 quarters · filed 2026-08-24 |
| 2024-06-30 | $7.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $15.20M derived: sum of 2 quarters · filed 2026-08-24 | $27.95M derived: sum of 3 quarters · filed 2026-08-24 | $38.04M 10-K · filed 2026-08-24 |
| 2024-03-31 | $8.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-08 | $20.89M derived: sum of 2 quarters · filed 2025-05-08 | $30.98M 10-Q · filed 2025-05-08 | $28.89M derived: sum of 4 quarters · filed 2025-08-22 |
| 2023-12-31 | $12.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-06 | $22.85M 10-Q · filed 2025-02-06 | $20.76M derived: sum of 3 quarters · filed 2025-08-22 | $30.87M derived: sum of 4 quarters · filed 2025-08-22 |
| 2023-09-30 | $10.09M 10-Q · filed 2024-11-05 | $8.01M derived: sum of 2 quarters · filed 2025-08-22 | $18.12M derived: sum of 3 quarters · filed 2025-08-22 | $34.86M derived: sum of 4 quarters · filed 2025-08-22 |
| 2023-06-30 | -$2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | $8.03M derived: sum of 2 quarters · filed 2025-08-22 | $24.77M derived: sum of 3 quarters · filed 2025-08-22 | $39.23M 10-K · filed 2025-08-22 |
| 2023-03-31 | $10.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-06 | $26.85M derived: sum of 2 quarters · filed 2024-05-06 | $41.31M 10-Q · filed 2024-05-06 | $49.72M derived: sum of 4 quarters · filed 2024-08-22 |
| 2022-12-31 | $16.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-07 | $31.20M 10-Q · filed 2024-02-07 | $39.61M derived: sum of 3 quarters · filed 2024-08-22 | $47.68M derived: sum of 4 quarters · filed 2024-08-22 |
| 2022-09-30 | $14.46M 10-Q · filed 2023-11-07 | $22.87M derived: sum of 2 quarters · filed 2024-08-22 | $30.94M derived: sum of 3 quarters · filed 2024-08-22 | $44.91M derived: sum of 4 quarters · filed 2024-08-22 |
| 2022-06-30 | $8.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22 | $16.48M derived: sum of 2 quarters · filed 2024-08-22 | $30.45M derived: sum of 3 quarters · filed 2024-08-22 | $42.18M 10-K · filed 2024-08-22 |
| 2022-03-31 | $8.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-08 | $22.04M derived: sum of 2 quarters · filed 2023-05-08 | $33.78M 10-Q · filed 2023-05-08 | $43.59M derived: sum of 4 quarters · filed 2023-08-23 |
| 2021-12-31 | $13.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | $25.71M 10-Q · filed 2023-02-07 | $35.51M derived: sum of 3 quarters · filed 2023-08-23 | $46.16M derived: sum of 4 quarters · filed 2023-08-23 |
| 2021-09-30 | $11.74M 10-Q · filed 2022-11-07 | $21.55M derived: sum of 2 quarters · filed 2023-08-23 | $32.19M derived: sum of 3 quarters · filed 2023-08-23 | $47.77M derived: sum of 4 quarters · filed 2023-08-23 |
| 2021-06-30 | $9.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $20.45M derived: sum of 2 quarters · filed 2023-08-23 | $36.03M derived: sum of 3 quarters · filed 2023-08-23 | $48.98M 10-K · filed 2023-08-23 |
| 2021-03-31 | $10.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-09 | $26.22M derived: sum of 2 quarters · filed 2022-05-09 | $39.17M 10-Q · filed 2022-05-09 | $45.19M derived: sum of 4 quarters · filed 2022-08-24 |
| 2020-12-31 | $15.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-07 | $28.53M 10-Q · filed 2022-02-07 | $34.55M derived: sum of 3 quarters · filed 2022-08-24 | $42.40M derived: sum of 4 quarters · filed 2022-08-24 |
| 2020-09-30 | $12.95M 10-Q · filed 2021-11-08 | $12.95M 10-Q · filed 2020-11-09 | $26.82M derived: sum of 3 quarters · filed 2022-08-24 | $36.95M derived: sum of 4 quarters · filed 2022-08-24 |
| 2020-06-30 | $6.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24 | $13.87M derived: sum of 2 quarters · filed 2022-08-24 | $24.00M derived: sum of 3 quarters · filed 2022-08-24 | $32.37M 10-K · filed 2022-08-24 |
| 2020-03-31 | $7.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-07 | $17.98M derived: sum of 2 quarters · filed 2021-05-07 | $26.35M 10-Q · filed 2021-05-07 | $34.48M derived: sum of 4 quarters · filed 2021-08-25 |
| 2019-12-31 | $10.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-08 | $18.50M 10-Q · filed 2021-02-08 | $26.62M derived: sum of 3 quarters · filed 2021-08-25 | $32.35M derived: sum of 4 quarters · filed 2021-08-25 |
| 2019-09-30 | $8.37M 10-Q · filed 2019-11-06 | $8.37M 10-Q · filed 2020-11-09 | $22.22M derived: sum of 3 quarters · filed 2021-08-25 | $29.08M derived: sum of 4 quarters · filed 2021-08-25 |
| 2019-06-30 | $8.13M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25 | $13.85M derived: sum of 2 quarters · filed 2021-08-25 | $20.71M derived: sum of 3 quarters · filed 2021-08-25 | $32.28M 10-K · filed 2021-08-25 |
| 2019-03-31 | $5.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | $12.59M derived: sum of 2 quarters · filed 2020-05-11 | $24.15M 10-Q · filed 2020-05-11 | $38.80M derived: sum of 4 quarters · filed 2020-08-26 |
| 2018-12-31 | $6.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | $18.43M 10-Q · filed 2020-02-06 | $33.08M derived: sum of 3 quarters · filed 2020-08-26 | $37.83M derived: sum of 4 quarters · filed 2020-08-26 |
| 2018-09-30 | $11.56M 10-Q · filed 2019-11-06 | $26.22M derived: sum of 2 quarters · filed 2020-08-26 | $30.97M derived: sum of 3 quarters · filed 2020-08-26 | $36.01M derived: sum of 4 quarters · filed 2020-08-26 |
| 2018-06-30 | $14.65M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26 | $19.40M derived: sum of 2 quarters · filed 2020-08-26 | $24.45M derived: sum of 3 quarters · filed 2020-08-26 | $28.24M 10-K · filed 2020-08-26 |
| 2018-03-31 | $4.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-07 | $9.79M derived: sum of 2 quarters · filed 2019-05-07 | $13.59M 10-Q · filed 2019-05-07 | $17.00M derived: sum of 4 quarters · filed 2019-11-06 |
| 2017-12-31 | $5.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07 | $8.84M 10-Q · filed 2019-02-07 | $12.25M derived: sum of 3 quarters · filed 2019-11-06 | $16.23M derived: sum of 4 quarters · filed 2019-11-06 |
| 2017-09-30 | $3.79M 10-Q · filed 2018-11-07 | $7.21M derived: sum of 2 quarters · filed 2019-11-06 | $3.79M 10-Q · filed 2017-11-09 | $15.24M derived: sum of 4 quarters · filed 2019-11-06 |
| 2017-06-30 | $3.41M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | $7.39M derived: sum of 2 quarters · filed 2019-11-06 | $11.44M derived: sum of 3 quarters · filed 2019-11-06 | $14.63M 10-K/A · filed 2019-11-06 |
| 2017-03-31 | $3.97M 10-Q · filed 2017-05-10 | $8.03M derived: sum of 2 quarters · filed 2017-05-10 | $11.22M 10-Q · filed 2018-05-09 | $13.96M derived: sum of 4 quarters · filed 2018-08-27 |
| 2016-12-31 | $4.05M 10-Q · filed 2017-02-09 | $7.25M 10-Q · filed 2018-02-08 | $9.98M derived: sum of 3 quarters · filed 2018-08-27 | $12.30M derived: sum of 4 quarters · filed 2018-08-27 |
| 2016-09-30 | $3.18M 10-Q · filed 2016-11-09 | $5.93M derived: sum of 2 quarters · filed 2018-08-27 | $3.19M 10-Q · filed 2017-11-09 | $10.57M derived: sum of 4 quarters · filed 2018-08-27 |
| 2016-06-30 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-27 | $5.07M derived: sum of 2 quarters · filed 2018-08-27 | $7.39M derived: sum of 3 quarters · filed 2018-08-27 | $9.43M 10-K · filed 2018-08-27 |
| 2016-03-31 | $2.32M 10-Q · filed 2017-05-10 | $4.64M derived: sum of 2 quarters · filed 2017-05-10 | $6.68M 10-Q · filed 2017-05-10 | $7.91M derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-12-31 | $2.32M 10-Q · filed 2017-02-09 | $4.36M 10-Q · filed 2017-02-09 | $5.59M derived: sum of 3 quarters · filed 2017-09-07 | $6.88M derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-09-30 | $2.04M 10-Q · filed 2016-11-09 | $3.27M derived: sum of 2 quarters · filed 2017-09-07 | $4.56M derived: sum of 3 quarters · filed 2017-09-07 | $6.63M derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-06-30 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $2.52M derived: sum of 2 quarters · filed 2017-09-07 | $4.59M derived: sum of 3 quarters · filed 2017-09-07 | $5.96M 10-K · filed 2017-09-07 |
| 2015-03-31 | $1.29M 10-Q · filed 2016-05-10 | $3.36M derived: sum of 2 quarters · filed 2016-05-10 | $4.72M 10-Q · filed 2016-05-10 | $5.61M derived: sum of 4 quarters · filed 2016-08-29 |
| 2014-12-31 | $2.08M 10-Q · filed 2016-02-09 | $3.44M 10-Q · filed 2016-02-09 | $4.33M derived: sum of 3 quarters · filed 2016-08-29 | $5.07M derived: sum of 4 quarters · filed 2016-08-29 |
| 2014-09-30 | $1.36M 10-Q · filed 2015-11-09 | $2.25M derived: sum of 2 quarters · filed 2016-08-29 | $2.99M derived: sum of 3 quarters · filed 2016-08-29 | |
| 2014-06-30 | $888.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | $1.63M derived: sum of 2 quarters · filed 2016-08-29 | $3.52M 10-K · filed 2016-08-29 | |
| 2014-03-31 | $740.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11 | $2.63M 10-Q · filed 2015-05-11 | ||
| 2013-12-31 | $1.90M 10-Q · filed 2015-02-09 | |||
| 2013-06-30 | $1.86M 10-K · filed 2015-08-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |